Drug screening and treatment for HIV thymocyte depletion
US5612018A · kind A · utility
5Cited by
0References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 18, 1994 |
| Grant date | Mar 18, 1997 |
| Priority date | — |
| Expiry date | Jan 18, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2517/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method is provided for screening compounds for the ability to supress thymocyte depletion in thymuses of HIV-infected individuals, particularly enhancing the CD4.sup.+ -expressing population as compared to an untreated individual. Particularly, drugs are provided which allow for this result, cyclosporine A being exemplary.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.